Tooth Eruption
Conditions
Interventions
This study will be divided into two distinct phases using the amber bracelet or necklace. In phase 1, children of both genders, seen at the Pediatric Dentistry Clinic of the Faculty of Dentistry of th
group B: will use the placebo necklace
group C: will not use the necklace, followed by filling in the questionnaire Venham's picture test (VPT) to assess anxiety, together with the measurement of heart rate and cortisol test, through the s
Other
D05.750.078.840.109
Sponsors
Faculdade de Odontologia da UFRJ
Faculdade de Odontologia da UFRJ
Eligibility
Age
8 Months to 12 Years
Inclusion criteria
Inclusion criteria: The inclusion criteria in the sample will be babies between 8 and 36 months of age who have at least one erupting primary dentition tooth (without natal or neonatal teeth) and that the parents are already familiar with the initial symptoms of the tooth eruption; The inclusion criteria in the sample 2 will be children between 7 and 12 years old who already have a history of anxious profile in dental consultations; showing fear and apprehension during consultations, making dental care difficult and completing the questionnaire have moderate to high anxiety results.
Exclusion criteria
Exclusion criteria: The exclusion criteria will be children with cognitive impairment (assessed by the pediatrician); history of medical treatment for any systemic disease that may influence the signs and symptoms of teething; current drug treatment, not using drugs for local use; use of teethers that relieve the symptoms of tooth eruption and pacifiers; oral or dental anomalies or deficiencies; and lack of parental consent to participate in the research. Exclusion criteria in phase 2 will be children with cognitive impairment (assessed by the pediatrician), history of medical treatment for any systemic disease that may influence the signs and symptoms of anxiety, children with hormonal problems related to cortisol or who use corticosteroids for up to 30 days prior to the beginning of the research; current drug treatment, including tranquilizers and anxiolytics, both pharmaceutical and natural; which may interfere with the results of the use of the amber necklace; as well as the lack of consent from parents or children to participate in the research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In the first phase of the study, it is expected to relieve with the use of the bracelet the signs and symptoms of the dental eruption, being measured through the application of a questionnaire (it was created and will be validated) applied to the parents.;In the second phase of the study, it is expected to improve the level of anxiety during dental consultations with the continuous use of amber stone that will be measured by measuring heart rate, salivary cortisol level and by the Venham's test questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| First phase of the study: Effect of the amber bracelet through the release of succinic acid signs and symptoms of tooth eruption, such as: irritation, excess salivation, fever as well as others; in babies aged 8 to 36 months, comparing with the responses obtained with the use of the placebo bracelet, and without the use of the bracelet, through the application of the questionnaire that will contain improvements or not related to the tooth eruption process, before and after the use of the bracelet.;In the second phase of the study: the effect of using the amber bracelet through the release of succinic acid, as an anxiolytic and calming agent, and the possible improvement of it, in children aged 7 to 12 years, being measured by measuring the heartbeat , salivary cortisol level and the Venham's test. | — |
Countries
Brazil
Contacts
Public ContactMatheus Pithon
UFRJ- Universidade Federal do Rio de Janeiro
Outcome results
None listed